Clinical trials
Active, not recruiting Observational Autism Spectrum Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Children's Hospital | 3 |
| National Taiwan University Hospital | 2 |
| Elizabeth Kilbey | 1 |
| Fondazione Don Carlo Gnocchi ETS | 1 |
| Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 1 |
| IRCCS National Neurological Institute "C. Mondino" Foundation | 1 |
| Oregon Health and Science University | 1 |
| University of Arkansas | 1 |
| University of Bari | 1 |
| University of Campania Luigi Vanvitelli | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autism Spectrum Disorder | 13 |
| Autistic Disorder | 5 |
| Asperger Syndrome | 3 |
| Intellectual Disability | 2 |
| Anxiety Disorders | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Child Development Disorders, Pervasive | 1 |
| Language Disorders | 1 |
| Learning Disabilities | 1 |
| Medically Unexplained Symptoms | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.